222 related articles for article (PubMed ID: 19235040)
1. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women.
Qin W; Zhu W; Shi H; Hewett JE; Ruhlen RL; MacDonald RS; Rottinghaus GE; Chen YC; Sauter ER
Nutr Cancer; 2009; 61(2):238-44. PubMed ID: 19235040
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.
Setchell KD; Brown NM; Zhao X; Lindley SL; Heubi JE; King EC; Messina MJ
Am J Clin Nutr; 2011 Nov; 94(5):1284-94. PubMed ID: 21955647
[TBL] [Abstract][Full Text] [Related]
3. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
[TBL] [Abstract][Full Text] [Related]
4. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast.
Hargreaves DF; Potten CS; Harding C; Shaw LE; Morton MS; Roberts SA; Howell A; Bundred NJ
J Clin Endocrinol Metab; 1999 Nov; 84(11):4017-24. PubMed ID: 10566643
[TBL] [Abstract][Full Text] [Related]
5. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women.
Lu LJ; Anderson KE; Grady JJ; Nagamani M
J Clin Endocrinol Metab; 2001 Jul; 86(7):3045-52. PubMed ID: 11443166
[TBL] [Abstract][Full Text] [Related]
6. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.
Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW
Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
[TBL] [Abstract][Full Text] [Related]
8. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.
Lu LJ; Anderson KE; Grady JJ; Kohen F; Nagamani M
Cancer Res; 2000 Aug; 60(15):4112-21. PubMed ID: 10945618
[TBL] [Abstract][Full Text] [Related]
9. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial.
Delmanto A; Nahas-Neto J; Traiman P; Uemura G; Pessoa EC; Nahas EA
Menopause; 2013 Oct; 20(10):1049-54. PubMed ID: 23481125
[TBL] [Abstract][Full Text] [Related]
10. Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women.
Kwak HS; Park SY; Kim MG; Yim CH; Yoon HK; Han KO
J Korean Med Sci; 2009 Oct; 24(5):867-73. PubMed ID: 19794985
[TBL] [Abstract][Full Text] [Related]
11. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
[TBL] [Abstract][Full Text] [Related]
12. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.
Wu AH; Yu MC; Tseng CC; Twaddle NC; Doerge DR
Carcinogenesis; 2004 Jan; 25(1):77-81. PubMed ID: 14555615
[TBL] [Abstract][Full Text] [Related]
13. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.
Fang MZ; Chen D; Sun Y; Jin Z; Christman JK; Yang CS
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7033-41. PubMed ID: 16203797
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.
Bloedon LT; Jeffcoat AR; Lopaczynski W; Schell MJ; Black TM; Dix KJ; Thomas BF; Albright C; Busby MG; Crowell JA; Zeisel SH
Am J Clin Nutr; 2002 Nov; 76(5):1126-37. PubMed ID: 12399289
[TBL] [Abstract][Full Text] [Related]
15. Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial.
Pop EA; Fischer LM; Coan AD; Gitzinger M; Nakamura J; Zeisel SH
Menopause; 2008; 15(4 Pt 1):684-92. PubMed ID: 18446090
[TBL] [Abstract][Full Text] [Related]
16. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Khan SA; Chatterton RT; Michel N; Bryk M; Lee O; Ivancic D; Heinz R; Zalles CM; Helenowski IB; Jovanovic BD; Franke AA; Bosland MC; Wang J; Hansen NM; Bethke KP; Dew A; Coomes M; Bergan RC
Cancer Prev Res (Phila); 2012 Feb; 5(2):309-19. PubMed ID: 22307566
[TBL] [Abstract][Full Text] [Related]
17. Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults.
Frankenfeld CL; Patterson RE; Kalhorn TF; Skor HE; Howald WN; Lampe JW
J Am Diet Assoc; 2002 Oct; 102(10):1407-13. PubMed ID: 12396157
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
19. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
20. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
Koo J; Cabarcas-Petroski S; Petrie JL; Diette N; White RJ; Schramm L
BMC Cancer; 2015 Nov; 15():905. PubMed ID: 26573593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
